Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02793219
Title Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UTHealth Memorial Hermann Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field